Faricimab 28.8mg/0.24ml solution for injection vials
NHS hospitals in England used £62,444,448 of indicative cost of Faricimab 28.8mg/0.24ml solution for injection vials in the 12 months to April 2026, about 0.2% of all hospital medicines spend. That is down 79.8% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Faricimab 28.8mg/0.24ml solution for injection vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Faricimab 28.8mg/0.24ml solution for injection vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Manchester University Nhs Ft | £8,657,414 |
| Moorfields Eye Hospital Nhs Ft | £7,753,279 |
| University Hpls North Midlands Nhs Trust | £5,341,681 |
| Royal Cornwall Hospitals Nhs Trust | £4,663,794 |
| Worcestershire Acute Hpls Nhs Trust | £4,054,467 |
| Barkinghavering & Redbridge Hpls Trst | £3,134,906 |
| Cambridge Univ Hosp Nhs Foundation Trust | £2,942,081 |
| Torbay And South Devon Nhs Foundation Tr | £2,696,979 |
| Salford Royal Nhs Foundation Trust | £1,939,391 |
| Western Sussex Hospitals Nhs Found Trust | £1,616,302 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.